ONCAlert | Upfront Therapy for mRCC
Bladder Cancer: Articles
A Look Back at FDA News from April 2019
2:22 PM, Wed May 1, 2019
Balar Shares Perspective on Key Findings From His Presentation at the 2019 GU Cancers Symposium
6:47 PM, Fri April 19, 2019
Interim Analysis of KEYNOTE-057 Shows Encouraging Antitumor Activity in NMIBC
9:14 PM, Fri April 12, 2019
Erdafitinib Granted FDA Approval in Bladder Cancer
7:02 PM, Fri April 12, 2019
Enfortumab Vedotin Effective in Urothelial Carcinoma After Chemo and Immunotherapy
3:16 PM, Thu March 28, 2019
Bladder Cancer Guidelines Highlight Arrival of Immunotherapy
5:39 PM, Mon March 25, 2019
Unique Immunotherapy Combinations Provide an Optimistic Outlook in Early Urothelial Carcinoma Trials
2:26 PM, Mon March 11, 2019
